Fintech PR
Harnessing the Transformative Power of Cold Chain Logistics with SSI Schaefer
SINGAPORE and DUBAI, UAE and RIYADH, Saudi Arabia, Jan. 2, 2024 /PRNewswire/ — As average global temperatures rise and the demand for cold-chain storage grows worldwide, SSI Schaefer, a global leader in intralogistics and automated warehouses, is sharing best practices and key considerations on how logistics and operations managers can optimize efficiency and cost-effectiveness of cold storage warehouses.
To explore SSI Schaefer’s comprehensive, tailored solutions for key upcoming facility projects, please contact its experts at [email protected].
Cold storage warehouse managers — particularly in the food and beverage industries, but also pharmaceutical distribution — are facing the need to efficiently and effectively store, pick, retrieve, pack, and ship perishable and sensitive goods, which require special handling, monitoring, and carefully tuned environmental conditions. Yet they face additional challenges — the cold-chain storage market is expanding, with some reports projecting a CAGR of 9% from 2023 to 2028, meaning that warehouse managers must balance surging demand for cold-stored goods with the increasing need to reduce energy costs and carbon emissions.
“What we are seeing for refrigerated supply chains is this pinch — a need to do ever more with ever less,” notes Carsten Spiegelberg, Managing Director – Middle East & Africa, SSI Schaefer. “To meet the growing complexities of the industry, it’s not enough to find a quick fix. Companies need material flow experts with industry know-how to consider all angles of a facility and seamlessly blend cold-chain logistics solutions with individual processes.”
Cold chain storage solutions
Careful planning is always the first step in optimizing temperature-controlled infrastructure. To increase efficiency and cost-effectiveness of cold storage warehouses, there are several factors to consider from the beginning.
Optimizing air circulation and product storage density
Since different products and comestibles require different storage temperatures, cold storage warehouse temperatures can range from -34°C to 0°C, with some even reaching 21°C. However, there is often a trade-off between storage density and air flow. Selecting the right storage system that enhances the cooled air circulation while increasing the storage density in the given facility footprint is critical in the planning phase.
Semi-automated solutions for cold storage space optimization
Ideal for deep-freeze facilities for bulk storage in the manufacturing sector and delivering maximum space utilization, channel storage setups with semi-automated drive-in racking systems are an accessible step towards automation, offering high throughput, enhanced safety, and reduced time for workers in refrigerated facilities. Capable of following either the Last in-First Out (LIFO) or the First in-Last Out (FIFO) principle, these systems use channel vehicles like SSI Orbiter® and a corresponding docking station to store and retrieve pallets.
Compared to a static, manual pallet rack system, a mobile racking storage system is an effective way to boost storage capacity in a given space — by up to 85%, while maintaining full selectivity typically required in distribution centers. This system involves racks that move along floor rails via electric motors to create an aisle only where needed, and it offers smart lighting that only activates in occupied aisles for reducing energy consumption, as well as a night parking option that optimizes rack spacing for maximal cold air circulation.
Future-ready automation systems for a seamless, cost-optimized cold chain
Due to the need for cold goods to maintain strict timetables and a closed cold chain, storage systems must handle incoming goods efficiently and cope with expected and unexpected upticks in demand. The best way to systematically manage the complexities of cold-chain material flows is with a fully automated storage system that seamlessly interconnects components, such as:
Pallets:
- Automated storage & retrieval systems (ASRSs): The SSI Exyz is an automated high-density storage system with extremely high space utilization, particularly in high-bay warehouses, and it saves 25% of energy compared to conventional machines while functioning across different temperatures.
- Shuttle solutions: As a future-proof, fully automated channel storage option, the SSI Lift & Run Shuttle System (SLR) provides simultaneous access to multiple racks for top-tier performance and high storage density.
Other storage types:
- Shuttle solutions for layer trays: For high-volume picking of goods such as comestibles for shop deliveries, tray shuttles and conveying systems enable fully automated robotic picking or support efficient semi-automatic goods-to-person picking.
- Storage solutions for container, bin and carton loads: For loads of varying dimensions, scalable solutions using SSI Miniload, Flexi Shuttle or Cuby maximize storage density while accommodating specific load and performance requirements to support automatic or semi-automatic case and piece picking.
Platforms for central control of refrigerated facilities
Although there are various warehouse automation technologies that track material flows, issues such as coordinating multiple systems often arise and there is a clear need for centralized monitoring and control — particularly with the complexities of refrigerated facilities. To tie all aspects of a cold storage warehouse together, end-to-end software such as WAMAS® or SAP EWM (Extended Warehouse Management) offer clear visualizations and comprehensive tools to manage processes, resources, and stock levels.
Company Profile SSI Schaefer Group
The SSI Schaefer Group is a leading global solution provider for all areas of intralogistics. With innovative technologies and software, the company empowers small to medium-sized enterprises as well as large companies to increase the efficiency and sustainability of their storage, picking, and transport processes — offering complete solutions spanning fully automated warehouses with tailored service and maintenance packages, to robotics and automated guided vehicles, to manual and semi-automatic systems such as workstations, racks, and containers.
For further information: https://www.ssi-schaefer.com/en-sg
Photo – https://mma.prnewswire.com/media/2309364/EDEKA_325_HRL_Exyz_1_corr.jpg
Photo – https://mma.prnewswire.com/media/2309365/Rheinfelsquelle_069_HRL_Exyz_ED__1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/harnessing-the-transformative-power-of-cold-chain-logistics-with-ssi-schaefer-302024393.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News4 days ago
Bank of Spain grants Amadeus’ Outpayce EMI licence
-
Latest News4 days agoGenome and Chilli Partners join forces to revolutionize iGaming affiliate payouts
-
Latest News4 days ago
Newmark Reports First Quarter 2024 Financial Results
-
Latest News4 days ago
EQT to acquire WSO2, a leading global provider of digital transformation technologies
-
Latest News4 days ago
Lunar Poised for Nationwide Rollout in Sweden After Securing €24.1 Million in Funding
-
Latest News4 days ago
REALTY ONE GROUP CELEBRATES 19TH ANNIVERSARY WITH GLOBAL ‘ONE DAY’ OF VOLUNTEERING & GIVING BACK
-
Latest News4 days ago
BIZCLIK MEDIA LAUNCHES MAY EDITION OF FINTECH MAGAZINE
